Similarly, IL-15 and IL-21 were designed to be fused with the anti-PD-1 antibody to yield fusion proteins αPD-1-IL-15R and PD-1Ab21, respectively, for tumor rejection [130, 191]. This evidence concerns the gene IL15 and neoplasm.